She is among many patients now asking why, with no apparent change in their blood test results, chronic kidney disease (CKD) is suddenly appearing as a problem on their medical charts. The answer is ...

Adults with type 2 diabetes and chronic kidney disease have a lower risk for adverse renal outcomes with semaglutide, ...

Mineralys Therapeutics announced positive topline results from its phase 2 Explore-CKD trial, in which lorundrostat lowered ...

Investigators studied apixaban pharmacokinetics, pharmacodynamics, and hemorrhage risk by kidney function. Kidney function is a major predictor of hemorrhage among patients with atrial fibrillation ...

We randomly assigned participants with chronic kidney disease (estimated glomerular filtration rate [eGFR], 30 to 90 ml per minute per 1.73 m 2 of body-surface area), albuminuria (a urinary ...

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

High blood pressure, also known as Hypertension, is a chronic, most life-long, irreversible condition in which the force of ...

The global Renal Function Test Market is estimated to be valued at USD 969.7 million in 2025 and is projected to reach USD 1,736.7 million by 2035, registering a CAGR of 6.0% over the forecast period.

It’s important for clinicians to assess patients undergoing percutaneous coronary intervention (PCI) for both anemia and chronic kidney disease (CKD).

Kidney failure, a silent killer, often goes unnoticed as the body adapts, masking symptoms like fatigue and swelling. The ...

In summary, chronic kidney disease progresses slowly and is divided into five stages based on how well the kidneys are ...

A biomarker panel can improve prediction of chronic kidney disease (CKD) progression in children, according to a study ...